Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Recommendations on the use of palivizumab: update 2023].
Fattore MJ, Maccarrone AJA, Brusadin M, Arbio MS, Saá G; Grupo Palivizumab SAP. Fattore MJ, et al. Arch Argent Pediatr. 2024 Jul 18:e202410430. doi: 10.5546/aap.2024-10430. Online ahead of print. Arch Argent Pediatr. 2024. PMID: 39008634 Free article. Spanish.
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. Faksova K, et al. Among authors: giglio n. Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12. Vaccine. 2024. PMID: 38350768 Free article.
Efficacy of an extensively hydrolyzed formula with the addition of synbiotics in infants with cow's milk protein allergy: a real-world evidence study.
Soria R, Del Compare M, Sallaberry M, Martín G, Aprigliano G, Hermida V, Carosella M, Gruenberg M, Monsell S, Micone P, Maciero E, Giglio N. Soria R, et al. Among authors: giglio n. Front Allergy. 2023 Oct 9;4:1265083. doi: 10.3389/falgy.2023.1265083. eCollection 2023. Front Allergy. 2023. PMID: 37876766 Free PMC article.
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis.
Phillips A, Jiang Y, Walsh D, Andrews N, Artama M, Clothier H, Cullen L, Deng L, Escolano S, Gentile A, Gidding G, Giglio N, Junker T, Huang W, Janjua N, Kwong J, Li J, Nasreen S, Naus M, Naveed Z, Pillsbury A, Stowe J, Vo T, Buttery J, Petousis-Harris H, Black S, Hviid A. Phillips A, et al. Among authors: giglio n. Vaccine. 2023 Oct 6;41(42):6227-6238. doi: 10.1016/j.vaccine.2023.08.079. Epub 2023 Sep 5. Vaccine. 2023. PMID: 37673715 Free article.
Meningococcal burden of disease in Argentina: 10 years epidemiologic review.
Neyro S, Urueña A, Efron A, Rancaño C, Pannunzio ME, Seoane MB, Gomez JA, Giglio N. Neyro S, et al. Among authors: giglio n. Hum Vaccin Immunother. 2023 Aug 1;19(2):2237391. doi: 10.1080/21645515.2023.2237391. Hum Vaccin Immunother. 2023. PMID: 37614151 Free PMC article.
81 results